MedTrace Logo

Comparison of the Effect of Cyclizine Versus Metoclopramide on Gastric Residual Volume in Patients Undergoing Bariatric Surgery: A Randomized Double-blinded Clinical Trial

NCT06789614 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2025-01-23

No results posted yet for this study

Summary

The aim of this work is to compare the effects metoclopramide versus Cyclizine withing the context of multimodal antiemetic strategy on GRV in patients scheduled for bariatric surgery.

Conditions

  • Bariatric Surgery

Interventions

DRUG

intravenous CYCLIZINE ,Metaclopromide

US giuded measure of GRV in bariatrics surgery upon recieving drugs of study

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-18
Primary Completion
2025-09-18
Completion
2025-10-18

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06789614 on ClinicalTrials.gov